New trial aims to make U500 (more concentrated) insulin easier to take.
Clinical Trials
Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.
34 readers recommended
Currently recruiting in people newly diagnosed with type 1.
40 readers recommended
Testing TypeZero’s inControl artificial pancreas, six months at a time.
35 readers recommended
What are the implications for other injected GLP-1 agonist drugs?
29 readers recommended
Program designed for Medicaid and uninsured individuals at risk for diabetes. Omada Health recently announced the launch of Prevent for Underserved Populations. The new...
42 readers recommended
Enrolling at over 140 sites worldwide. Can it reduce A1c and insulin use and improve time-in-range?
31 readers recommended
Find nearby T1D, T2D, gestational diabetes, and complications trials with new clinical trials matching tool launched by JDRF and TrialReach
21 readers recommended
A six-month study of Diasome Pharmaceuticals’ HDV Insulin in Type 1 Diabetes
27 readers recommended
Recruiting participants in Boston at the Joslin Diabetes Center
51 readers recommended
A real-world trial in 3,000+ participants currently enrolling participants with type 2 diabetes
37 readers recommended
A six-week study of Tandem’s first automated insulin delivery device with Dexcom’s G5 CGM
39 readers recommended
Trial results testing sotagliflozin and Farxiga in type 1 diabetes show greater A1c lowering and weight loss, plus continued conversation about small risk of DKA
40 readers recommended
Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health
42 readers recommended
Comparing Medtronic’s MiniMed 670G to injections and pumps in people with type 1 diabetes, with and without CGM; enrollment to open in May at some trial locations
42 readers recommended
Learn more about the All of Us Research Program, a massive national effort to collect individual health data to support precision medicine research
33 readers recommended
Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C...
45 readers recommended
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2...
51 readers recommended
A new trial will test if the once-weekly injectable, Bydureon, is also safe and effective in adolescents.
54 readers recommended
Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...
44 readers recommended
Phase 3 clinical trial currently recruiting 400 adults with type 2 diabetes